Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations.

Kodjikian, Laurent; Parravano, Mariacristina; Clemens, Andreas; Dolz-Marco, Rosa; Holz, Frank G; Munk, Marion R.; Nicolò, Massimo; Ricci, Federico; Silva, Rufino; Talks, S James; Verma, Rohini Kumar; Zarranz-Ventura, Javier; Zweifel, Sandrine A (2021). Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations. Eye, 35(8), pp. 2119-2135. Nature Publishing Group 10.1038/s41433-021-01487-0

[img]
Preview
Text
s41433-021-01487-0.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Current guidelines on the management of patients with neovascular age-related macular degeneration (nAMD) lack clear recommendations on the interpretation of fluid as seen on optical coherence tomography (OCT) imaging and the incorporation of this information into an ongoing disease treatment strategy. Our objective was to review current guidelines and scientific evidence on the role of fluid as a biomarker in the management of nAMD, and develop a clinically oriented, practical algorithm for diagnosis and management based on a consensus of expert European retinal specialists. PubMed was searched for articles published since 2006 relating to the role of fluid in nAMD. A total of 654 publications were screened for relevance and 66 publications were included for review. Of these, 14 were treatment guidelines, consensus statements and systematic reviews or meta-analyses, in which OCT was consistently recommended as an important tool in the initial diagnosis and ongoing management of nAMD. However, few guidelines distinguished between types of fluid when providing recommendations. A total of 52 publications reported primary evidence from clinical trials, studies, and chart reviews. Observations from these were sometimes inconsistent, but trends were observed with regard to features reported as being predictive of visual outcomes. Based on these findings, diagnostic recommendations and a treatment algorithm based on a treat-and-extend (T&E) regimen were developed. These provide guidance on the diagnosis of nAMD as well as a simple treatment pathway based on the T&E regimen, with treatment decisions made according to the observations of fluid as a critical biomarker for disease activity.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Munk, Marion

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0950-222X

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Marion Munk

Date Deposited:

11 May 2021 12:17

Last Modified:

26 Jul 2021 01:32

Publisher DOI:

10.1038/s41433-021-01487-0

PubMed ID:

33795837

BORIS DOI:

10.48350/155512

URI:

https://boris.unibe.ch/id/eprint/155512

Actions (login required)

Edit item Edit item
Provide Feedback